The results of the univariate Cox regression indicated that six immune indicators (HLA class II on TILs, PD-L1 on TILs, CD3, CD4, CD8, and FOXP3) were significantly associated with RFS in patients with SCLC. This evidence concerns the gene FOXP3 and small cell lung carcinoma.